Clinical Trials · NCT07313813
A Study to Evaluate the Effect of Fasting Duration and Dulaglutide (LY2189265) Withholding on Gastric Retention in Participants With Type 2 Diabetes Mellitus
- Phase
- Phase 1
- Recruitment status
- Active Not Recruiting
- Sponsor
- Eli Lilly and Company
- Enrollment
- 20
- Start date
- Dec 2025
- Locations
- 1 site, Singapore
- Primary endpoint
- Percentage of Fasting Participants with Lack of Gastric Content Retention Post-Solid Test Meal